Claritev Corporation
Claritev Corporation (CTEV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CTEV · as of Jun 8, 2026
Key Statistics
Explore Claritev Corporation Data
ctev stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 75.0%
The CTEV analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $39.25, representing +51.90% upside from the current price of $25.84.
Competitors & Peers
ctev competitorsCTEV
AXGN
DNTH
EVH
GDRX
IARTStock Performance
Full HistoryAbout Claritev Corporation
Claritev Corporation together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United …
what is claritev corporation · ctev stock overview · claritev corporation company profile · who is claritev corporation ceo · ctev NYSE · claritev corporation headquarters · claritev corporation business segments
About Stock Overview & Key Data
Claritev Corporation (CTEV) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NYSE since Apr 3, 2020. As of the latest trading session, CTEV stock price is $25.84, with a market capitalization of $440.5M. The stock has returned -32.95% over the past 12 months and -39.56% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Claritev Corporation stock is Buy, with an average 12-month price target of $39.25. In fiscal year 2025, Claritev Corporation reported revenue of $965.4M and net income of -$284.3M. For detailed data — including Claritev Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Claritev Corporation (CTEV) stock price is $25.84. The stock is traded on NYSE under the ticker symbol CTEV. The 52-week range is $11.50 – $74.07.